title: Buffy coat PCR for diagnosis of experimental pneumococcal pneumonia.
abstract: An immunocompetent murine model of pneumococcal pneumonia and bacteremia was used to evaluate a PCR assay based on amplification of the pneumolysin gene. Mice were treated with trovafloxacin to determine the decline in sensitivity of PCR as lung bacterial concentrations decreased and blood cultures became sterile. Forty-three mice were studied for up to 120 h after start of antibiotic treatment. PCR of buffy coat specimens was more sensitive than PCR of plasma. Only 21% of animals had a positive blood culture, whereas 77% of PCR buffy coat assays were positive. After 48 h of therapy all blood culture specimens were sterile, whereas buffy coat PCR was positive in 57.8% of specimens. PCR of buffy coat specimens was negative in all mice colonized nasally with Streptococcus pneumoniae and in rabbits with Escherichia coli bacteremia. Our results demonstrate that our PCR technique using buffy coat specimens is highly specific for invasive pneumococcal disease and remains positive in the majority of animals for at least 48 h after start of antibiotic therapy.
authors.affiliation: The University of Texas Southwestern Medical Center, Dallas, USA. wng@kkh.com.sg
authors.forename: W
authors.initials: W
authors.lastname: Ng
authors.forename: K
authors.initials: K
authors.lastname: Olsen
authors.forename: I
authors.initials: I
authors.lastname: Lutsar
authors.forename: L
authors.initials: L
authors.lastname: Wubbel
authors.forename: F
authors.initials: F
authors.lastname: Ghaffar
authors.forename: H
authors.initials: H
authors.lastname: Jafri
authors.forename: G H
authors.initials: GH
authors.lastname: McCracken
authors.forename: I R
authors.initials: IR
authors.lastname: Friedland
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001426:Bacterial Proteins; D001769:Blood / Q000382:microbiology*; D015169:Colony Count, Microbial; D005260:Female; D024841:Fluoroquinolones; D008168:Lung / Q000382:microbiology; D051379:Mice; D008807:Mice, Inbred BALB C; D009287:Naphthyridines / Q000627:therapeutic use; D011018:Pneumonia, Pneumococcal / Q000175:diagnosis* / Q000188:drug therapy; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D011817:Rabbits; D012680:Sensitivity and Specificity; D013296:Streptococcus pneumoniae / Q000235:genetics / Q000254:growth & development / Q000302:isolation & purification*; D013301:Streptolysins / Q000235:genetics
chemical_list: D000890:Anti-Infective Agents; D001426:Bacterial Proteins; D024841:Fluoroquinolones; D009287:Naphthyridines; D013301:Streptolysins; C032290:plY protein, Streptococcus pneumoniae; C080163:trovafloxacin